Press Releases Search News Category Company ReleasesCompany StatementsFinancial ReleasesProduct Releases Year None202320222021202020192018201720162015201420132012201120102009200820072006 Date Title PDF Version Jan 30, 2020 Alexion Reports Fourth Quarter and Full Year 2019 Results Jan 28, 2020 Alexion Completes Acquisition of Achillion Jan 24, 2020 UPDATED TIME: Alexion Fourth Quarter and Full Year 2019 Results Conference Call at 7:30am ET on Thursday, January 30, 2020 Jan 17, 2020 Alexion to Report Fourth Quarter and Full Year 2019 Results on Thursday, January 30, 2020 Jan 14, 2020 Alexion Announces Planned Initiation of Pivotal Phase 3 Study of ULTOMIRIS® (ravulizumab) in ALS Jan 06, 2020 Alexion to Present at the 38th Annual J.P Morgan Healthcare Conference Dec 16, 2019 Alexion Exercises Option for Two Additional GalXC™ RNAi Programs for Complement-Mediated Targets Under Collaboration With Dicerna™ Dec 06, 2019 Alexion Issues Statement on Path to Value Creation Nov 26, 2019 Alexion to Present at the 2019 Evercore ISI HealthCONx Nov 22, 2019 SOLIRIS® (eculizumab) Receives Approval in Japan for the Prevention of Relapse in Patients with Neuromyelitis Optica Spectrum Disorder (NMOSD) Pagination First page « first Previous page ‹ previous … Page 4 Page 5 Page 6 Page 7 Current page 8 Page 9 Page 10 Page 11 Page 12 … Next page next › Last page last » Displaying 71 - 80 of 626